You are viewing: Rest Of South America Elastomeric Infusion Pumps Market analysis

The Rest Of South America Elastomeric Infusion Pumps Market was valued at $11.1 Million in 2025 and projected to reach to $13.7 Million by 2030, representing a compound annual growth rate of CAGR 4.2%. Rest Of South America's elastomeric infusion pumps market is positioned for moderate but consistent growth through 2030.

Rest Of South America Elastomeric Infusion Pumps Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of South America Elastomeric Infusion Pumps Market Trends and Insights

  • Rest Of South America represents a developing segment within the broader South American medical device landscape, where elastomeric infusion pumps are increasingly adopted for ambulatory and home-based drug delivery applications.
  • The region's growth is supported by rising healthcare expenditure, improving access to advanced medical technologies, and growing prevalence of chronic diseases requiring continuous infusion therapy. Rest Of South America's market dynamics are shaped by regulatory frameworks, healthcare infrastructure development, and the gradual shift toward patient-centric care models.
  • Rest Of South America is experiencing steady demand for cost-effective infusion solutions, particularly in countries with expanding middle-class populations and modernizing healthcare systems.
  • Between 2025 and 2030, Rest Of South America is expected to benefit from increased clinical adoption, improved distribution networks, and growing awareness among healthcare providers regarding the advantages of elastomeric infusion pumps over traditional intravenous delivery methods..

Key Market Statistics

  • CAGR (2025-2030) CAGR 4.2%
  • Market Size, 2025 ~USD 11.1 Million
  • Forecast, 2030 ~USD 13.7 Million
  • Country Rest Of South America

Rest Of South America Elastomeric Infusion Pumps Market Overview

Market Size & Growth :

Rest Of South America's elastomeric infusion pumps market is valued at USD 11.1 million in 2025, with projected growth to USD 13.7 million by 2030, representing a steady CAGR of 4.2%.

Ambulatory Care Adoption :

Elastomeric infusion pumps are gaining traction in Rest Of South America for ambulatory and home-based patient care, driven by increasing preference for portable drug delivery solutions and reduced hospital dependency.

Regional Healthcare Development :

Rest Of South America represents an emerging segment within South American medical device markets, with growing healthcare infrastructure investments and rising awareness of advanced infusion technologies among healthcare providers.

Below-Global Growth Rate :

At 4.2% CAGR, Rest Of South America's market growth trails the global elastomeric infusion pumps market at 5.3%, indicating untapped potential and opportunities for market penetration and expansion.

Rest Of South America Elastomeric Infusion Pumps Market Dynamics

  • The region's developing healthcare infrastructure and increasing adoption of ambulatory care models are driving demand for portable infusion solutions.
  • Healthcare providers in Rest Of South America are progressively recognizing the clinical and economic benefits of elastomeric pumps for chronic disease management and oncology applications. The market outlook remains positive despite growth rates below global averages, reflecting the region's emerging status in medical device adoption.
  • Expanding middle-class populations, improved healthcare access, and rising chronic disease prevalence are expected to support market expansion.
  • Strategic partnerships between international device manufacturers and local distributors will be critical to accelerating market penetration in Rest Of South America..

Related Ecosystem

Key Takeaways

  • Rest Of South America's elastomeric infusion pumps market is valued at USD 11.1 million in 2025 with a projected value of USD 13.7 million by 2030.
  • Rest Of South America is experiencing a steady 4.2% CAGR, reflecting moderate but consistent market expansion driven by healthcare modernization.
  • Rest Of South America's growth is supported by rising chronic disease prevalence, improved healthcare infrastructure, and increasing adoption of ambulatory infusion therapies.
  • Rest Of South America represents an emerging opportunity for medical device manufacturers seeking to expand in developing South American markets with cost-effective infusion solutions.

Elastomeric Infusion Pumps Market Report Scope

Report Metric Details
Base Year 2025
Fastest Growing Segment HOME CARE SETTINGS (Setting)
Forecast Period 2025–2030
Growth Rate CAGR of 5.3% from 2025 to 2030
Largest Segment ACCESSORIES AND CONSUMABLES (Product)
Market Size Base Year (Billions) ~USD 1.15 (2025)
Revenue Forecast (Billions) ~USD 1.49 (2030)
Segments Covered Type, Application, End-Use Industry, Product, Setting

Rest Of South America Elastomeric Infusion Pumps Market Report Segmentation

5 segment dimensions are covered across the global market.

By Type

  • Continuous Rate
  • Variable Rate

By Application

  • Analgesia/Pain Management
  • Antibiotics
  • Chemotherapy
  • Chemotherapy/Oncology
  • Diabetes Management
  • Gastroenterology
  • Hematology
  • Other Applications
  • Pain Management
  • Pediatrics/Neonatology

By End-Use Industry

  • Ambulatory Surgical Centers (Ascs)
  • Homecare Settings
  • Hospitals
  • Other End-Use Industries

By Product

  • Accessories And Consumables
  • Devices

By Setting

  • Academic And Research Institutes
  • Ambulatory Care Settings
  • Home Care Settings
  • Hospitals

Target Audience

  • Medical Device Manufacturers : Manufacturers seeking to expand elastomeric infusion pump portfolios into Rest Of South America need region-specific market data, growth projections, and competitive insights to guide product development and commercialization strategies.
  • Healthcare Distributors & Suppliers : Regional distributors require detailed market sizing and demand forecasts for Rest Of South America to optimize inventory planning, negotiate supplier agreements, and identify high-potential customer segments for elastomeric pumps.
  • Healthcare Providers & Hospital Networks : Hospital administrators and procurement teams in Rest Of South America need market trend analysis and technology adoption data to make informed purchasing decisions and evaluate elastomeric pump solutions for ambulatory care programs.
  • Investment & Private Equity Firms : Investors evaluating opportunities in South American medical device markets require Rest Of South America-specific market intelligence, growth trajectories, and competitive dynamics to assess portfolio companies and acquisition targets.
  • Healthcare Consultants & Analysts : Consulting firms advising healthcare organizations and device manufacturers need comprehensive Rest Of South America market data to develop strategic recommendations, feasibility studies, and market entry plans for elastomeric infusion pump solutions.

Key Companies in the Rest Of South America Elastomeric Infusion Pumps Market

CompanyHQOwnershipStrongest segments
BAXTERUnited StatesPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
NIPROJapanPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
AVNSUnited StatesPrivate CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
WOOYOUNG MEDICAL CO., LTD.South KoreaPrivate CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Electronic Infusion Pumps (adjacent),
SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.ChinaPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Accessories & Disposables for Elastomeric Pumps,
AMBU A/SDenmarkPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
DAIKEN MEDICAL CO., LTD.JapanPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate / PCA Elastomeric Pumps,Chemotherapy Applications,

BAXTER

Baxter is a publicly traded American healthcare company founded in 1931 that employs 37,500 people. The company operates in the medical devices and pharmaceuticals sector.

NIPRO

Nipro is a Japanese public company founded in 1947 with 38,593 employees operating in the medical devices sector. The company serves global healthcare markets.

AVNS

AVNS is a privately held American company founded in 2014 with 2,287 employees. The company operates in the medical devices industry.

WOOYOUNG MEDICAL CO., LTD.

Wooyoung Medical Co., Ltd. is a privately held South Korean company founded in 1996. The company operates in the medical devices sector.

SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.

Shanghai Int Medical Instruments Co., Ltd. is a publicly traded Chinese medical device company founded in 2006 with 2,088 employees. The company serves the healthcare market.

AMBU A/S

Ambu A/S is a publicly traded Danish medical device company founded in 1937 with 5,200 employees. The company specializes in emergency and surgical equipment.

DAIKEN MEDICAL CO., LTD.

Daiken Medical Co., Ltd. is a publicly traded Japanese medical device company founded in 1968 with 185 employees. The company serves the healthcare industry.

Reasons to Buy this Report

  • Regional Market Sizing & Forecasts : Obtain precise market valuation for Rest Of South America (USD 11.1M in 2025, USD 13.7M in 2030) with detailed CAGR analysis to support investment decisions and market entry strategies specific to this emerging region.
  • Competitive Landscape Intelligence : Understand market dynamics, key players, and competitive positioning within Rest Of South America's elastomeric infusion pump segment to identify partnership and acquisition opportunities in this developing market.
  • Growth Driver Analysis : Identify region-specific factors driving the 4.2% CAGR, including ambulatory care adoption, healthcare infrastructure development, and chronic disease prevalence to tailor product positioning and marketing strategies.
  • Market Entry & Expansion Strategy : Leverage Rest Of South America-specific insights to develop localized go-to-market strategies, distribution partnerships, and regulatory compliance roadmaps for successful market penetration in this underserved segment.
  • Investment & Risk Assessment : Evaluate market maturity, growth potential, and risk factors unique to Rest Of South America to make informed capital allocation decisions and forecast ROI for elastomeric infusion pump business expansion.

Frequently asked questions

What is the current market size of elastomeric infusion pumps in Rest Of South America?

Rest Of South America's elastomeric infusion pumps market is estimated at USD 11.1 million in 2025.

What is the projected market size for elastomeric infusion pumps in Rest Of South America by 2030?

Rest Of South America's elastomeric infusion pumps market is projected to reach USD 13.7 million by 2030.

What is the CAGR for the elastomeric infusion pumps market in Rest Of South America?

Rest Of South America's elastomeric infusion pumps market is expected to grow at a CAGR of 4.2% from 2025 to 2030.

What factors are driving growth in Rest Of South America's elastomeric infusion pumps market?

Rest Of South America's market growth is driven by rising healthcare expenditure, increasing chronic disease prevalence, improved healthcare infrastructure, and growing adoption of ambulatory infusion therapies.

How does Rest Of South America's elastomeric infusion pumps market compare to other South American regions?

Rest Of South America represents a developing segment within South America, with steady growth potential as healthcare systems modernize and access to advanced medical technologies expands across the region.

RESEARCH METHODOLOGY

The study involved four major activities to estimate the current size of the global elastomeric infusion pumps market. Exhaustive secondary research was conducted to gather information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of elastomeric infusion pumps through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the elastomeric infusion pumps market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

Secondary Research

The market for companies offering elastomeric infusion pumps is determined by secondary data obtained from paid and unpaid sources, analyzing the product portfolios of major companies in the ecosystem, and evaluating companies based on their performance and quality. Various secondary sources, including Business Standard, Bloomberg, the World Bank, and Factiva, were consulted to identify and collect information for this study on the elastomeric infusion pumps market. During the secondary research process, various secondary sources were consulted to identify and collect information relevant to the study. Secondary sources included annual reports, press releases, investor presentations of door vendors, forums, certified publications, and white papers. The secondary research was utilized to gather critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from both market- and technology-oriented perspectives.

Primary Research

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the elastomeric infusion pump market. After completing the market engineering process (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers derived. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of elastomeric infusion pumps offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

The following is the breakdown of primary respondents:

Elastomeric Infusion Pumps Market

Notes: Other designations include sales, marketing, and product managers. Tier 1: >USD 1 Billion; Tier 2: USD 500 million–1 Billion; and Tier 3: < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were employed to estimate and validate the size of the global elastomeric infusion pumps market. These methods were also widely used to assess the size of various related market segments. The research methodology used to determine the market size included the following:

Elastomeric Infusion Pumps Market

Data Triangulation

After determining the overall market size using market size estimation processes, the market was segmented into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Elastomeric infusion pumps are portable, non-electronic medical devices designed for the controlled delivery of drugs, such as analgesics, antibiotics, and chemotherapeutic agents, over a specified period. These devices utilize the elastic properties of specific elastomers to deliver accurate, continuous, or intermittent medication infusions without requiring batteries or external power sources. Elastomeric infusion pumps are recognized for their simplicity, reliability, and ease of use, making them suitable for use in hospital, outpatient, and home care environments. They are produced and tested in accordance with international medical device standards, including ISO 13485 for quality management, ISO 11608 for infusion device efficacy, and ASTM standards for elastomeric materials. The devices are extensively utilized in oncology, pain management, anesthesia, and palliative care, enhancing patient compliance, mobility, and safety. Elastomeric infusion pumps are crucial to the advancement of the field of patient-centered drug delivery and healthcare innovation, particularly in home healthcare and ambulatory care.

Stakeholders

  • Elastomeric infusion pump manufacturers
  • Raw material suppliers
  • Converters & processors
  • Distributors and traders
  • Industry associations and regulatory bodies
  • End users

Report Objectives

  • To define, describe, and forecast the size of the global elastomeric infusion pumps market, based on type, end-use industry, and region in terms of value and volume
  • To provide detailed information on the significant drivers, restraints, opportunities, and challenges influencing the market
  • To strategically analyze micromarkets concerning individual growth trends, prospects, and their contribution to the market
  • To assess the growth opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
  • To forecast the market size of segments and subsegments for North America, Europe, Asia Pacific, South America, and the Middle East & Africa
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • To analyze competitive developments such as acquisitions, expansions, partnerships, and agreements in the elastomeric infusion pumps market
  • To provide the impact of AI/Gen AI on the market

Get the Full Elastomeric Infusion Pumps Market Report

Full forecast, segment splits, and company analysis for all Elastomeric Infusion Pumps Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status